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Abstract A non-structural protein of the hepatitis C virus 
(HCV), NS3, contains amino acid sequence motifs characteristic 
of serine-proteinases and RNA helicases. RNA binding activity 
of the NS3 protein with an apparent dissociation constant of 
2 x 10 -7 M was detected using a poly(U)-Sepharose r sin. Com- 
petitive RNA binding analysis suggested that the NS3 protein 
binds preferentially to the poly(U) sequence, which is located 
at the 3' end of HCV RNA. Mutational analysis of NS3 protein 
revealed the possibility that both the RNA helicase region and the 
serine-proteinase region were necessary for full RNA binding 
activity. 
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1. Introduction 
Hepatitis C virus (HCV) is a positive strand RNA virus. The 
RNA,  approximately 9.4 kb in length, contains a single large 
open reading frame encoding about 3,010 amino acids and a 
poly(U) of 30 to 100 nucleotides at the 3' end. Although cDNA 
sequences of several HCV strains have been determined [1 5], 
little is known about the virus-specific RNA replication. Fur- 
thermore, viral polypeptides involved in RNA replication of 
HCV have not been identified. 
Comparative analyses using available nucleotide sequences 
of flaviviruses and pestiviruses have suggested that the NS3 and 
NS5b proteins of HCV may be possible enzymatic omponents 
of the viral RNA replicase. The HCV NS3 protein (about 70 
kDa) contains motifs for serine-proteinase in the N-terminal 
third and of NTPases and RNA helicase in the C-terminal 
portion, respectively. Indeed, enzymatic activity of the serine- 
proteinase which mediates everal cleavages in the viral pro- 
teins has been demonstrated [6-8] and partially purified C- 
terminal fragments of NS3 protein has been shown to have 
NTPase activity [9]. Recently, the NS3 protein of bovine viral 
diarrhea virus (BVDV), a member of pestivirus has been re- 
ported to possess RNA helicase activity [10]. 
In the present study, we have established an assay system for 
detecting the RNA binding activity of recombinant NS3 pro- 
tein of HCV by using poly(U)-Sepharose r sin. The NS3 pro- 
tein has been shown to preferentially bind to the poly(U) se- 
quence suggesting that the NS3 protein may have an affinity 
to the 3' end of HCV RNA.  
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2. Materials and methods 
2.1. Construction of expression vectors 
A DNA fragment corresponding to the NS3 protein (amino acid 
positions 1011 to 1608) of HCV strain R6 was prepared by polymerase 
chain reactions using the region-specific oligonucleotides a primers. 
These oligonucleotides were designed to provide the PCR product 
EeoRI and XhoI sites at the 5' and 3' termini, respectively. The 
amplified DNA fragments were cut with EcoRI and XhoI restriction 
enzymes and cloned into pET-21b vector (Novagen). All the mutants 
contained the T7.tag sequence coding for the 11 amino acid of the 
N-terminal peptide of T7 gene 10 protein at the 5' termini, as well as 
the sequence for 6 consecutive histidine residues (His. tag) at 3' termini 
as an affinity tag for purification. The structural organization of these 
mutants (termed pETNS3F and pETNS3gl ~69) were summarized in
Fig. 1. 
2.2. Expression and isolation of His.tagged NS3 protein 
E. coli BL21(DE3) were transformed with expression plasmids. The 
transformed cells grew logarithmically in LB medium containing 50 
pg/ml ampicillin and then supplemented with 0.4 mM isopropyl-),-D- 
thiogalactopyranoside (IPTG). After 2 h of further growth at 37°C, the 
cells were harvested by centrifugation (5,000 x g for 5 min at 4°C) and 
suspended inbuffer A (20 mM Tris-HC1 (pH 7.9),500 mM NaC1, 5 mM 
imidazole) with brief sonication. Inclusion bodies of His-tagged NS3 
proteins were collected by centrifugation (40,000 x g for 15 min at 4 ° C) 
and resuspended in buffer A containing 5 M guanidine-HC1 with soni- 
cation. After incubation for one hour on ice, the extract was centrifuged 
as above. 
NS3 proteins were purified batchwise using NiZ+-Sepharose column 
chromatography in the presence of 5 M guanidine-HC1 as described in 
the instruction manual (Novagen). The purified proteins were re- 
natured by dialysis against buffer B (50 mM HEPES-KOH (pH7.4), 50 
mM NaC1, lmM EDTA, 0.02% 2-mercaptoethanol, 0.01% Triton X- 
100, 20% glycerol) containing 0.5 M guanidine-HCl overnight and then 
against buffer B without guanidine-HC1 twice. The dialysates were 
cleared by centrifugation and stored at -80°(5:. 
2.3. RNA binding assay 
The RNA binding assay was performed with approximately 15 pg 
of partially purified NS3 protein fraction from NF+-Sepharose column 
chromatography (the purity of all NS3 protein derivatives was about 
50% on SDS-polyacrylamide geleIectrophoresis). The protein solutions 
were incubated with 0.025 g of poly(U)-Sepharose b ads (Pharmacia) 
in 600/11 of buffer B for 2.5 h at 4°C. Beads were centrifuged and 
washed five times with buffer B containing 0.5 M or 1.0 M NaCI. After 
washing, proteins were eluted in SDS-loading buffer and analyzed by 
SDS-polyacrylamide g l electrophoresis (5-15%). NS3 protein were 
detected by staining with Brilliant blue G (Sigma) or immunoblotting 
using NS3 protein specific monoclonal antibody 3D3 (a gift from Dr 
Akira Hasegawa) and IgG coupled to alkaline phosphatase (Bio-Rad). 
The amount of all NS3 protein derivatives was estimated by scanning 
Brilliant blue G-stained SDS-polyacrylamide g ls with a computing 
densitometer (ACI). The total amount of protein in each fraction was 
determined with Bradford assay using BSA as standard. 
For competition analysis, an excess amount of homoribopolymers; 
poly(A), poly(U), poly(C) and poly(G) (Pharmacia) were pre-incubated 
with an NS3 protein fraction for 30 min on ice, and then poly(U)- 
Sepharose beads were added to the reaction mixture. After washing, 
NS3 proteins were detected by staining with Brilliant blue G. 
All rights reserved. 
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Fig. 1. Schematic presentation f NS3 protein-deletion mutants. The 
relative positions of the mutant NS3 proteins are shown. T7. Tag, tag 
sequence of T7 gene 10; NTP, NTP-binding consensus equence; 
R. Rich, arginine-rich sequence; His-Tag, 6 consecutive histidine resi- 
dues. Numbers indicate the amino acid position corresponding to the 
HCV NS3 protein [1,3,7]. 
3. Results and discussion 
In order to obtain an abundant source of HCV NS3 protein 
for biochemical analysis, we subcloned a series of DNA frag- 
ments, encoding the NS3 protein into E. coli expression vector. 
All constructs are schematically represented in Fig. 1. We 
mainly used two constructs to establish the system of the RNA- 
binding assay. One was a plasmid pETNS3F containing most 
of the coding sequences of NS3 protein (both the serine-pro- 
teinase domain and the putative helicase domain). The other 
was the plasmid pETNS3gl containing the nucleotide sequence 
encoding only the putative helicase domain. All recombinant 
proteins were fused at their N-termini to the T7.Tag sequence 
and C-termini to the His'Tag sequence. The proteins, NS3F 
and NS3gl were expressed in E. coli BL21(DE3) in the presence 
of IPTG and partially purified using Ni2+-Sepharose column 
chromatography. The NS3~I protein was expressed as a pol- 
ypeptide at about 55 kDa (lanes resin(-)) and was detected by 
the NS3 protein-specific monoclonal antibody 3D3 (Fig. 2A, 
column b). 
The RNA binding activity of the NS3 protein was detected 
using poly(U)-Sepharose beads. As shown in Fig. 2A, in the 
partially purified fraction of the Ni2+-Sepharose column, only 
the NS3~I protein was bound to the poly(U)-Sepharose b ads 
and the protein was immuno-reactive to the NS3-specific anti- 
body. Conversely, the NS3gl protein did not bind with control 
Sepharose beads. This demonstrates that the system could de- 
tect NS3 protein-specific RNA binding activity in the solution. 
To establish the basis for delineating the RNA binding activity 
of the NS3 protein, we determined the affinity (apparent equi- 
librium dissociation constant, K~) of NS3F and NS38I pro- 
teins. Fig. 2B shows the normalized binding curves. NS3F pro- 
tein had a five times higher affinity (K d = 2 × 10 -7 M) than 
NS3gl protein (K d = 1 × 10 -6 M). Since we washed the poly(U)- 
Sepharose beads with buffer containing 0.5 M NaC1 (see sec- 
tion 2) to detect he NS3-specific RNA binding activity in the 
system, the real Kd value of NS3F protein was probably more 
than 2 × 10 -7 M. The results suggested that the putative RNA 
helicase region of the NS3 protein may be responsible for the 
specific RNA binding activity and showed how the serine- 
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Fig. 2. (A) Detection of the RNA binding activity in a partially purified 
fraction of the HCV NS3 protein. (a) Plasmid pETNS3~I (see Fig. 1) 
transformed into E. coli. The cell lysate of cultures either uninduced (-) 
or IPTG induced (+) were prepared and partially purified using Ni z+- 
Sepharose column chromatography. The partially purified protein 
(Lanes of resin (-)) were incubated with Sepharose or poly(U)-Sepha- 
rose beads. After washing with buffer B containing 0.5 M NaC1 (see 
section 2), bound proteins were eluted and analyzed by SDS-poly- 
acrylamide gel electrophoresis (5-15%). The gel was identified using 
Brilliant blue G staining. An arrow indicates the position of the NS361 
protein. (b) Immunoblot analysis of the same fraction in (a). (B) RNA 
binding curves of the NS3 protein. RNA binding activity was measured 
using poly(U)-Sepharose b ads. The data for each curve were normal- 
ized to the saturation point for each protein, NS3F(o) and NS3~I (A). 
The Kj value is equal to the protein concentration at which 50% of the 
highest RNA binding activity. 
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Fig. 3. Competitive RNA binding experiment. The NS3g;I protein was 
pre-incubated with 30 or 150 molar excess of homoribopolymers to that 
of NS3gl protein followed by the addition of poly(U)-Sepharose b ads. 
The NS3g;1 protein was analyzed as described in Fig. 2a. The relative 
RNA binding activities are indicated at the bottom. Similar esults were 
obtained from the several independent experiments. 
proteinase region enhanced activity. Thus, the whole NS3 pro- 
tein is likely required for stable RNA binding. 
To examine the specificity of RNA binding activity in the 
NS3 protein, we carried out the competitive RNA binding 
experiments. An excess amount of the four different homori- 
bopolymers were pre-incubated with the NS3 protein and de- 
gree of NS3 protein binding to the poly(U)-Sepharose b ads 
was analyzed. Little or no competition was observed when 
poly(A) or poly(C) was used as a competitor. Poly(G) partially 
blocked the poly(U) binding to the NS3 protein. Conversely, 
as shown in Fig. 3, the binding of NS3 protein to poly(U)- 
Sepharose beads was blocked in a dose-dependent manner by 
the presence of poly(U). This suggests that the NS3 protein has 
a binding activity specific for the poly(U) sequence. 
In order to determine the region(s) responsible for the RNA 
binding activity of the NS3 protein, we constructed a series of 
NS3 protein-deletion mutants (Fig. 1) and analyzed their RNA 
binding activity. Fig. 4A shows the expressions and partial 
purifications of the mutant proteins using Ni2+-Sepharose col- 
umn chromatography. All mutants were expressed and purified 
as the major protein in each fraction. After the RNA binding 
reaction followed by washing with a buffer containing 0.5 M 
NaCl, the NS3F protein was positively bound to poly(U)- 
Sepharose beads. Deletion of the serine-proteinase r gion 
(NS351 protein) had no effect on RNA binding activity. How- 
ever, deletions from any other region of the helicase domain 
(NS3~I protein) led to a significant reduction in RNA binding 
activity (Fig. 4B). Conversely, when the binding beads were 
washed with a buffer containing 1.0 M NaCI, only the NS3F 
protein was significantly retained in the beads (Fig. 4C). Similar 
results of the RNA binding activity of NS3 protein was ob- 
served using a Sepharose beads coupled with synthetic oligonu- 
cleotides corresponding tothe 3' end of HCV (data not shown). 
These results support our observations in Fig. 2B and further 
suggested that whole the NS3 protein is necessary for stable 
RNA binding. 
Recently, it has been reported that a short (10 to 20 amino 
acids) arginine-rich sequence and the motif defined as closely 
spaced Arg-Gly-Gly (RGG) repeats in viral, bacteriophage, 
and ribosomal protein-mediated RNA binding (for review see 
[11]). In the NS3 protein sequence, one cluster of basic amino 
acids (R-rich) was found between residues 478 and 494, 
RSQRRGRTGRGRRGIYR (Fig. 1). However, as shown in 
Fig. 4B,C, the two constructs (NS3~8 and NS3~9) containing 
R-rich region did not bind effectively to poly(U)-Sepharose 
beads, suggesting that the region might not be responsible for 
RNA binding activity in the whole NS3 protein. We synthe- 
sized several oligopeptides, one of which corresponded to the 
R-rich region of the NS3 protein, and tested them for RNA 
binding activity using gel shift analysis. The R-rich peptide 
region bound strongly to several RNA sequences. However, the 
NS3~I protein failed to bind to RNA sequences in the gel shift 
assay (data not shown). This suggests that the gel shift assay 
may be useful for detecting potential regions of RNA binding 
activity, but this region was not always responsible for activity 
in the whole RNA-binding molecule. Recently, the RNA bind- 
ing activity of the cellular helicase, eIF-4B [12] and viral heli- 
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Fig. 4. RNA binding activity of the mutant NS3 proteins. (A) Expres- 
sion and the partial purification (Ni2+-Sepharose column bound) of 
mutant proteins. Mutant NS3 proteins were analyzed using SDS-poly- 
acrylamide gel electrophoresis (5-15%), stained with Brilliant blue G. 
(B) Mutants proteins bound to poly(U)-Sepharose r sin after washing 
with buffer B containing 0.5 M NaC1. (C) Mutants proteins bound to 
poly(U)-Sepharose r sin after washing with buffer B containing 1.0 M 
NaCI. Products corresponding to individual deletion-mutants are 
marked with dots. 
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cases [10,13] has been detected by using a filter-binding assay. 
However, the binding specificity remains unclear. It is likely 
that the filter-binding assay is not suitable for determing the 
RNA-binding specificity. Thus, a binding assay using a resin 
coupled with the specific RNA sequence may be a useful tool 
for detecting the specificity of RNA-binding proteins such as 
RNA helicase. 
What is the biological role of poly(U) binding activity in the 
NS3 protein? NTPase activity of the helicase domain is known 
to be regulated by the presence of polyribonucleotides. In the 
case of the HCV NS3 protein, the NTPase activity was en- 
hanced by adding poly(U) to the reaction mixture [9]. HCV 
RNA may contain stable secondary structure in the sequence 
found just before the poly(U) stretches at the 3' end of the HCV 
genome [14]. The single-stranded 3' terminus is required for 
helicase activity in a BVDV NS3 protein [10] or a cellular 
helicase [16]. Based on these results and our observations, it is 
possible that the HCV NS3 protein binds to the 3' end of the 
HCV genome and regulates the positive strand replication of 
viral RNA. 
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